12:00 AM
Nov 19, 2012
 |  BC Week In Review  |  Company News  |  Deals

Ariad, Foundation Medicine deal

Foundation Medicine and Ariad partnered to apply Foundation Medicine's genomic profiling technologies to patients enrolled in Ariad's ongoing Phase I/II trial evaluating AP26113...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >